{
  "ptid_time": "114_S_0173_2014-02-11",
  "img_path": "/data/qiuhui/data/adni/images/114_S_0173/2014-02-11/t1.nii.gz",
  "img_finding": "",
  "text_data": "Age is 81.2 years. Gender is Male. Education: 18 years. MMSE: 30.0. MoCA: 23.0. Logical Memory: 9.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.36 SUVR (significant elevated); Amyloid beta: 868.60 pg/mL (normal ); Total tau: 343.60 pg/mL (mild elevated); Phosphorylated tau: 33.48 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "Reasoning: The patient has a normal MMSE score (30/30) but a borderline MoCA score (23/30), suggesting possible mild cognitive impairment. Elevated AV45 (amyloid PET) and moderately elevated P-tau indicate significant amyloid deposition and tau pathology, which are hallmarks of Alzheimer's disease, despite normal Aβ levels in CSF. The mild elevation in T-tau may reflect neurodegeneration.  \nDiagnosis: MCI (likely due to Alzheimer's pathology)  \nConfidence: Medium (clinical scores are borderline, but biomarkers strongly suggest early AD pathology)",
  "timestamp": "2025-07-26T11:38:53.305821"
}